TY - JOUR
AU - M. Raza
AU - H. Abeysundera
AU - G. Branjerdporn
A1 - 
AB - OBJECTIVE: The aim is to assess the impact of long-acting buprenorphine (LAI-BNP) on frequency of methamphetamine (MA) use. METHODS: We undertook an observational, descriptive, retrospective cohort study of patients of a public, tertiary, community-based Alcohol and Other Drug Service (AODS) with opioid use disorder (OUD) treated with LAI-BNP who are current or past users of MA. We assessed the changes of frequency of use in their MA use at start (baseline), 3 and 6 months of LAI-BNP. RESULTS: Study included 59 participants. Based on their MA use at the commencement of LAI-BNP, the sample was further sub-grouped as active users (n = 30) and past users (n = 29). At 6 months of LAI-BNP, all the past users remained abstinent from MA use. 70% (n = 21) of participants with active MA use had reduced or ceased their MA use while 17% (n = 5) increased their MA use at 6 months. CONCLUSIONS: The results favour the use of LAI-BNP as a potential treatment for MA use.
AD - Department of Psychiatry, Gold Coast University Hospital, Gold Coast, QLD, Australia.; Department of Psychiatry, Gold Coast University Hospital, Gold Coast, QLD, Australia; and School of Medicine, Griffith University, Gold Coast, QLD, Australia.
AN - 37478293
BT - Australas Psychiatry
C5 - Opioids & Substance Use
CP - 5
DA - Oct
DO - 10.1177/10398562231190211
DP - NLM
ET - 20230721
IS - 5
JF - Australas Psychiatry
LA - eng
N2 - OBJECTIVE: The aim is to assess the impact of long-acting buprenorphine (LAI-BNP) on frequency of methamphetamine (MA) use. METHODS: We undertook an observational, descriptive, retrospective cohort study of patients of a public, tertiary, community-based Alcohol and Other Drug Service (AODS) with opioid use disorder (OUD) treated with LAI-BNP who are current or past users of MA. We assessed the changes of frequency of use in their MA use at start (baseline), 3 and 6 months of LAI-BNP. RESULTS: Study included 59 participants. Based on their MA use at the commencement of LAI-BNP, the sample was further sub-grouped as active users (n = 30) and past users (n = 29). At 6 months of LAI-BNP, all the past users remained abstinent from MA use. 70% (n = 21) of participants with active MA use had reduced or ceased their MA use while 17% (n = 5) increased their MA use at 6 months. CONCLUSIONS: The results favour the use of LAI-BNP as a potential treatment for MA use.
PY - 2023
SN - 1039-8562
SP - 690
EP - 693+
ST - Impact of long-acting buprenorphine injection on methamphetamine use: A retrospective cohort study
T1 - Impact of long-acting buprenorphine injection on methamphetamine use: A retrospective cohort study
T2 - Australas Psychiatry
TI - Impact of long-acting buprenorphine injection on methamphetamine use: A retrospective cohort study
U1 - Opioids & Substance Use
U3 - 10.1177/10398562231190211
VL - 31
VO - 1039-8562
Y1 - 2023
ER -